The construction of German pharmaceutical plants will begin near Voronezh in 2016

German pharmaceutical organization Bionorica SE and Aenova GmbH will start in 2016 the construction of a pharmaceutical factory in the Voronezh region the price of 30 million euros, informs on the first day of the week, the government of the region.

Pharmaceutical companies Bionorica SE and Aenova GmbH first expressed interest in the implementation within the Voronezh region of the investment project on construction of a pharmaceutical company. Required plot was discovered within the industrial Park " Maslovsky ". On the first day of the week Voronezh Governor Alexey Gordeyev has agreed plans of pharmaceutical companies to build the company with CEO of Bionorica SE with Professor Michael Popp.

"One of the next steps will be the signing of the lease agreement of the land plot, which will take place in the near future. To start building businesses in our area Bionorica SE is planning in the coming year ", - is informed in the report. The amount of investment reached 30 million euros.

The project includes the construction of an enterprise for production of medicines by extraction from natural raw materials (herbs). Today, raw materials for manufacturing Firm grows in its own areas of Mallorca, however, the possibility for growing parts of medicinal herbs within the Voronezh region. Local company UAB "Pavlov field" under the contract with the firm laid the test field 4 medicinal crops and has already received the first results of which are evaluated as " good ".
Aenova GmbH is One of the leading contract manufacturers in the European Union. The range of activities the organization has absorbed the entire chain of the creation, development and creation of all major dosage forms, as well as dietary supplements. Bionorica SE is specialized in the production of phytotherapeutic drugs. The firm was founded in 1933 in Germany, the division opened in the Russian Federation in 1997. In Russia, as noted on the Internet representation of the organization, Bionorica is the market leader in drugs of plant origin. The company has subsidiaries in Russia, Germany, USA, Austria, China, Poland, Spain, UK and Ukraine.


sections: Politics